946513-99-1

Basic information

• Product Name: 4-nitrobenzoic acid (S)-(1-aza-bicyclo[2.2.2]oct-3-yl)ester fumarate
• Synonyms: 4-nitrobenzoic acid (S)-(1-aza-bicyclo[2.2.2]oct-3-yl)ester fumarate
• CAS NO: 946513-99-1
• Molecular Weight: 392.365
• Mol File: 946513-99-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-nitrobenzoic acid (S)-(1-aza-bicyclo[2.2.2]oct-3-yl)ester fumarate(CAS DataBase Reference)
• NIST Chemistry Reference: 4-nitrobenzoic acid (S)-(1-aza-bicyclo[2.2.2]oct-3-yl)ester fumarate(946513-99-1)
• EPA Substance Registry System: 4-nitrobenzoic acid (S)-(1-aza-bicyclo[2.2.2]oct-3-yl)ester fumarate(946513-99-1)

Safety Data

• Hazardous Substances Data: 946513-99-1(Hazardous Substances Data)

Upstream product

• 110-17-8 (2E)-but-2-enedioic acid 
• 25333-42-0 (R)-quinuclidin-3-ol 
• 62-23-7 4-nitro-benzoic acid 

Downstream Products

• 3684-26-2 (S)-quinuclidin-3-ol 

Relevant articles and documents

ENANTIOPURE QUINUCLIDINYLOXY PYRIDAZINES AND THEIR USE AS NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS

This invention relates to novel enantiopure azabicyclo pyridazinyloxy derivatives of formula (I), which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.